The latest closing stock price for SAB Biotherapeutics as of September 18, 2024 is 2.56.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-649 today, roughly -1 times their original investment - a -29.48% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.39, which is 149.6% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 0.41, which is 84% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.05.
An investor who bought $1,000 worth of SAB Biotherapeutics stock at the IPO in 2021 would have $-649 today, roughly -1 times their original investment - a -29.48% compound annual growth rate over 3 years.
The all-time high SAB Biotherapeutics stock closing price was 11.24 on December 01, 2021.
The SAB Biotherapeutics 52-week high stock price is 6.39, which is 149.6% above the current share price.
The SAB Biotherapeutics 52-week low stock price is 0.41, which is 84% below the current share price.
The average SAB Biotherapeutics stock price for the last 52 weeks is 3.05.